đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
Part A: The primary objective is to evaluate the safety and tolerability of...
Status
Completed
Location
Biokinetic Europ Ltd
Start Date
2015-05
Trial ID
NCT02459262
Treatments Being Tested
The objective of this extension study is the initial assessment of safety a...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-03-29
Trial ID
NCT02690181
Treatments Being Tested
Phase 1/2, randomized, placebo-controlled, observer-blinded study will eval...
Status
Completed
Location
Velocity Clinical Research
Start Date
2019-01-14
Trial ID
NCT03765073
Treatments Being Tested
This study will assess the impact on nasopharyngeal carriage, safety and im...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-02-09
Trial ID
NCT01262872
Collection of serum from women not living with HIV, who received the GBS6 v...
Status
Recruiting
Location
MUJHU Care Ltd, Kampala
Start Date
2026-03-27
Trial ID
NCT07562061
Treatments Being Tested
The purpose of this study is to evaluate the safety, reactogenicity and imm...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-01-08
Trial ID
NCT00814489
Treatments Being Tested
Evaluate the safety and immunogenicity of the trivalent group B streptococc...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-03-18
Trial ID
NCT02046148
Treatments Being Tested
This study looks at the body's immune responses to a GBS vaccine 2 years af...
Status
Completed
Location
Institute for Pharmacokinetic and Analytical Studies
Start Date
2010-01
Trial ID
NCT01052935
Treatments Being Tested
The purpose of the present study is to assess and compare in healthy non-pr...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-11-20
Trial ID
NCT02270944
Treatments Being Tested
This study will evaluate the safety, reactogenicity and immunogenicity of a...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-09-25
Trial ID
NCT00370396
Treatments Being Tested